Weight Medics Responds to MHRA Approval of Foundayo, Offering Guidance for Women With PCOS Related Weight Gain
Following the recent decision by the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise Foundayo (orforglipron) for weight management in the UK
On 10 August 2026, the MHRA approved Foundayo, making the United Kingdom the first country in Europe to authorise this once daily oral GLP1 receptor agonist. Foundayo is licensed for weight loss and weight maintenance in adults with a body mass index of 30 or above, or a body mass index between 27 and 30 alongside at least one weight related health condition. It is also authorised to support glycaemic control in adults with insufficiently managed type 2 diabetes.
Unlike some other oral weight loss medications, Foundayo does not require fasting or specific water intake rules around dosing, since it is a small molecule GLP1 agonist rather than a peptide based formulation. This may offer a more flexible daily routine for patients compared with existing oral options.
Why This Matters For Women With PCOS
Polycystic ovary syndrome, commonly known as PCOS, is closely linked to insulin resistance and hormonal imbalance, both of which can make weight management significantly more difficult than standard calorie reduction alone. Because PCOS is widely recognised as a weight related health condition, many women living with PCOS and a body mass index in the 27 to 30 range may fall within the eligibility criteria for treatments such as Foundayo, subject to individual clinical assessment.
"We are seeing growing numbers of women asking whether new treatments like Foundayo could help address the specific challenges PCOS creates around weight," said [INSERT SPOKESPERSON NAME AND TITLE], of Weight Medics. "Our priority is making sure every patient receives a proper clinical assessment first, so that any treatment recommended actually fits their individual health picture, rather than assuming one option suits everyone."
Access And Availability
Foundayo is a prescription only medicine and is not currently available through the NHS, as it remains subject to a separate evaluation by the National Institute for Health and Care Excellence (NICE) before routine NHS access can be considered. Private access is expected to become available through registered providers in the coming months.
Weight Medics is preparing to offer structured consultations for patients interested in Foundayo, with full eligibility assessments carried out before any prescribing decision is made. Patients considering treatment for PCOS related weight gain are encouraged to book an initial consultation to discuss their individual circumstances with a qualified clinician.
About Weight Medics
Weight Medics is a UK based weight loss clinic offering medically supervised consultations and treatment plans for adults seeking evidence based support with weight management, including conditions such as PCOS related weight gain. The clinic works with patients to assess suitability for a range of prescription treatments, always prioritising proper clinical oversight over self directed or unregulated approaches.
For more information or to book a consultation, visit [https://weightmedics.co.uk/]
Unlike some other oral weight loss medications, Foundayo does not require fasting or specific water intake rules around dosing, since it is a small molecule GLP1 agonist rather than a peptide based formulation. This may offer a more flexible daily routine for patients compared with existing oral options.
Why This Matters For Women With PCOS
Polycystic ovary syndrome, commonly known as PCOS, is closely linked to insulin resistance and hormonal imbalance, both of which can make weight management significantly more difficult than standard calorie reduction alone. Because PCOS is widely recognised as a weight related health condition, many women living with PCOS and a body mass index in the 27 to 30 range may fall within the eligibility criteria for treatments such as Foundayo, subject to individual clinical assessment.
"We are seeing growing numbers of women asking whether new treatments like Foundayo could help address the specific challenges PCOS creates around weight," said [INSERT SPOKESPERSON NAME AND TITLE], of Weight Medics. "Our priority is making sure every patient receives a proper clinical assessment first, so that any treatment recommended actually fits their individual health picture, rather than assuming one option suits everyone."
Access And Availability
Foundayo is a prescription only medicine and is not currently available through the NHS, as it remains subject to a separate evaluation by the National Institute for Health and Care Excellence (NICE) before routine NHS access can be considered. Private access is expected to become available through registered providers in the coming months.
Weight Medics is preparing to offer structured consultations for patients interested in Foundayo, with full eligibility assessments carried out before any prescribing decision is made. Patients considering treatment for PCOS related weight gain are encouraged to book an initial consultation to discuss their individual circumstances with a qualified clinician.
About Weight Medics
Weight Medics is a UK based weight loss clinic offering medically supervised consultations and treatment plans for adults seeking evidence based support with weight management, including conditions such as PCOS related weight gain. The clinic works with patients to assess suitability for a range of prescription treatments, always prioritising proper clinical oversight over self directed or unregulated approaches.
For more information or to book a consultation, visit [https://weightmedics.co.uk/]
- Contact Email
- [email protected]
- Issued By
- Weight Medics
- Phone
- 02077607670
- Business Address
- Advanced Weight Solutions Ltd - t/a Weight Medics, 65 Margaret St, London W1W 8SP, United Kingdom
- Country
- United Kingdom
- Categories
- Fitness · Healthcare
- Last Updated
- September 8, 2026